Here is the recording from Exopharm’s shareholder update webinar held on 13 July 2021.
Founder & CEO, Dr Ian Dixon, provided an update on RNA delivery using exosomes and developments relating to Exopharm’s LEAP technology IP. Following this, CCO/Deputy CEO, Dr Chris Baldwin discussed ongoing commercial activity relating to the Company.
The webinar was hosted by Senior Business Development Manager, Aislinn Treloar, and ended with a Q&A session.